In the SCN1A cohort, most individuals had Dravet syndrome (55/59; 93.2%), the remaining having other SCN1A-related DEEs. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.